HOME >> BIOLOGY >> NEWS
Double honor recognises world-class science and spin-out success

World-class pharmaceutical research undertaken at The University of Nottingham and at one of its highly successful spin-out companies has been recognised with the UKs most prestigious corporate accolade.

The Universitys School of Pharmacy, and spin-out company Molecular Profiles, a leader in the provision of innovative contract research services, have each won The Queens Award for Enterprise in the category of Innovation in 2007.

The award underlines The University of Nottinghams School of Pharmacys reputation as an international centre of excellence in research, with teaching and research teams in the UK and Malaysia delivering breakthrough results in biophysics, surface analysis, medicinal chemistry, structural biology, molecular and cellular sciences, drug delivery and tissue engineering. It is also a centre of excellence in social research in medicines and health.

The School and Molecular Profiles are singled out for enhancing significantly the development of new medicines.

The Universitys commitment to the creation of economic growth through technology transfer is reflected in the fact that two awards have been made, one to the University and one to Molecular Profiles Ltd, which is recognised for Innovation in the pharmaceutical and biomedical industries. Molecular Profiles works with most of the leading pharmaceutical companies globally, providing advanced analytical research through the combination of state-of-the-art instrumentation and scientific expertise. From its base in Nottingham the company has developed a reputation for the transfer of cutting-edge research to the world marketplace and has grown to be one of the UKs major success stories.

Sir Colin Campbell, Vice-Chancellor of The University of Nottingham, said: "This double recognition underlines the excellence of the research in our School of Pharmacy at its sites in the United Kingdom and at The University of Nottingham in Malaysia; it also reco
'"/>

Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
University of Nottingham
26-Apr-2007


Page: 1 2 3 4

Related biology news :

1. Double identities lie behind chromosome disorders
2. Double honors for diabetes researchers
3. Double trouble for RA patients: PLC-gamma-2 regulates osteoclastogenesis and B cell differentiation
4. Double-trouble: Cells with duplicate genomes can trigger tumors
5. Double trouble: Cells with duplicate genomes can trigger tumors
6. Double triumph in stem cell quest
7. Philadelphia ecologist receives top Mongolia honor
8. 5 OHSU faculty members singled out for honors
9. QUTs top researchers honored with fellowships
10. Science earns top honor from Spains Crown Prince
11. International team to honor 30th anniversary of deep-sea vent discovery in Galpagos

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first ... insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and ... be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in ... Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions ... data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... hospitalized patients with severe COVID-19. This is the first study of an XPO1 ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly regarded ... on the purchase of greenfield for a new, expanded manufacturing facility. The site ... acres in the initial acquisition, with an option to purchase an additional 21 ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... combine up to three different materials for use with CRM, neurostimulation, vascular, and ... three materials to meet specific design requirements, performance, and cost criteria; especially where ...
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
Breaking Biology Technology:
Cached News: